Venlo, the Netherlands, June 22, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it plans to provide in the first half of July 2020 an overview of preliminary results for the second quarter and first half of 2020, along with perspectives on anticipated business trends for the third quarter of... Read more
Initiative to enhance newborn screening in underserved populations for improved health outcomes in Africa WALTHAM, Mass. – June 18, 2020 – PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with the American Society of Hematology (ASH), the world’s largest professional society of hematologists, to support a... Read more
Shimadzu Corporation and RIKEN Innovation Co., Ltd. have signed an agreement to jointly start an R&D program based on measuring the function of the brain and the five senses. The two companies intend to contribute to society by having Shimadzu start new businesses based on research results achieved by RIKEN. RIKEN and Shimadzu Corporation have... Read more
An advanced laboratory dedicated to leading Wales’ national Covid-19 testing has been established in Cardiff, thanks to collaboration between Public Health Wales and one of the world’s leading diagnostics companies. Creating a national Covid-19 testing lab at the University Hospital of Wales is an important part of the Welsh Government’s Test, Trace, Protect strategy... Read more
Reliable, easy-to-use cryo-EM workflow solution quadruples throughput for pharma labs HILLSBORO, Ore., June 16, 2020 /PRNewswire/ — To help pharmaceutical companies obtain faster results in their drug discovery process and reduce the cost of bringing new drugs to market, Thermo Fisher Scientific has released the Thermo Scientific iSPA Workflow, the first commercially available single particle analysis (SPA) workflow... Read more
Company’s latest FDA EUA solution broadens RT-PCR and serology offerings available in the U.S. WALTHAM, Mass. – June 15, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer Company, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for... Read more
FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific’s Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients Designation follows recent announcement on development of first companion diagnostic using the Oncomine Precision Assay on the new Ion Torrent Genexus System CARLSBAD, Calif., June 15, 2020 /PRNewswire/ — The U.S. Food and Drug... Read more
Shimadzu’s Response to the COVID-19 Pandemic Read more
Addition of sFlt-1 for second and third trimester pre-eclampsia management rounds out portfolio WALTHAM, Mass. – June 10, 2020 – PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced today the addition of the DELFIA® Xpress sFlt-1 kit to its CE-IVD Read more